HomeInsightsStock Comparison

Bafna Pharmaceuticals Ltd vs Influx Healthtech Ltd Stock Comparison

Bafna Pharmaceuticals Ltd vs Influx Healthtech Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 89.45 as of 04 Jul 15:30.
  • The P/E Ratio of Bafna Pharmaceuticals Ltd is 0 as of March 2020 .The P/E Ratio of Influx Healthtech Ltd is 0 as of March 2020.
  • The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 2.1 crore as of March 2020 .The Market Cap of Influx Healthtech Ltd is ₹ 0 crore as of March 2020.
  • The revenue of Bafna Pharmaceuticals Ltd for the Mar '25 is ₹ 40.09 crore as compare to the Dec '24 revenue of ₹ 33.38 crore. This represent the growth of 20.1% The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Bafna Pharmaceuticals Ltd for the Mar '25 is ₹ 2.35 crore as compare to the Dec '24 ebitda of ₹ 3.24 crore. This represent the decline of -27.47% The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Bafna Pharmaceuticals Ltd changed from ₹ 6.35 crore to ₹ 1.31 crore over 8 quarters. This represents a CAGR of -54.58% The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to table results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 M...

Read more

21 May 2025 10:24

News

Bafna Pharmaceuticals announces board meeting date

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 Fe...

Read more

28 Jan 2025 17:34

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 2024 18:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 2024 10:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 2024 17:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 2024 13:56

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bafna Pharmaceuticals Ltd and Influx Healthtech Ltd

Which company has a larger market capitalization, Bafna Pharmaceuticals Ltd or Influx Healthtech Ltd?

Market cap of Bafna Pharmaceuticals Ltd is 211 Cr while Market cap of Influx Healthtech Ltd is 304 Cr

What are the key factors driving the stock performance of Bafna Pharmaceuticals Ltd and Influx Healthtech Ltd?

The stock performance of Bafna Pharmaceuticals Ltd and Influx Healthtech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bafna Pharmaceuticals Ltd and Influx Healthtech Ltd?

As of July 5, 2025, the Bafna Pharmaceuticals Ltd stock price is INR ₹89.45. On the other hand, Influx Healthtech Ltd stock price is INR ₹131.35.

How do dividend payouts of Bafna Pharmaceuticals Ltd and Influx Healthtech Ltd compare?

To compare the dividend payouts of Bafna Pharmaceuticals Ltd and Influx Healthtech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions